Skip to main content

Table 3 Immunization coverage by region among children aged 12–23 months during the DHS, 2010–2011

From: Determinants of complete immunization among senegalese children aged 12–23 months: evidence from the demographic and health survey

Vaccines National n = 2199 West n = 1534 North n = 246 East n = 136 South n = 283
BCG 2083 (94.70%) 1467 (95.63%) 228.6 (93.10%) 266 (94.00%) 119 (88.40%)
Polio 0a 1741 (79.20%) 1291 (84.13%) 180.4 (73.40%) 77 (57.43%) 191 (67.64%)
Penta1 2063 (93.80%) 1450 (94.45%) 224 (91.05%) 122 (89.00%) 279 (98.50%)
Penta 2 1998 (90.80%) 1414 (92.17%) 216 (87.80%) 114 (70.00%) 257 (90.81%)
Penta 3 1817 (82.60%) 1301 (84.81%) 188 (76.42%) 95 (69.80%) 238 (84.10%)
0PV1 2081 (94.60%) 1462 (95.30%) 225 (91.40%) 123 (90.40%) 272 (96.11%)
0PV2 1994 (90.70%) 1412 (92.04%) 212 (86.50%) 115 (84.60%) 257 (90.81%)
0PV3 1598 (72.70%) 1133 (73.85%) 169 (68.70%) 82 (60.74%) 218 (77.00%)
Measles 1805 (82.10%) 1133 (73.85%) 134 (54.50%) 62 (46.00%) 194 (66.87%)
All antigensb 1381 (62.80%) 996 (64.90%) 187 (76.01%) 101 (74.20%) 235 (83.30%)
  1. BCG Bacillus Calmette-Guerin
  2. Penta diphtheria, tetanus, pertussis, hepatitis B vaccine and haemophilus influenzae b
  3. 0PV Oral Polio Vaccine
  4. PCV Pneumococcus conjugated vaccine
  5. N weighted total number of children
  6. aPolio 0 is the oral polio vaccination given within 24 h after birth
  7. bIncludes a single dose of BCG vaccine, three doses of Pentavalent vaccines and three doses of Polio vaccine (excluding the birth) and the first dose of measles vaccine